May 3 (Reuters) - Brickell Biotech Inc BBI.O :
- BRICKELL BIOTECH ANNOUNCES SALE OF SOFPIRONIUM BROMIDE TO BOTANIX PHARMACEUTICALS
- BRICKELL BIOTECH INC - BOTANIX HAS ACQUIRED FROM BRICKELL ALL ASSETS PRIMARILY RELATED TO SOFPIRONIUM BROMIDE
- BRICKELL BIOTECH INC - BRICKELL WILL RECEIVE UPFRONT AND POTENTIAL NEAR-TERM REGULATORY MILESTONE PAYMENTS OVER NEXT 18 MONTHS OF UP TO $9 MILLION
- BRICKELL BIOTECH INC - BRICKELL ALSO IS ELIGIBLE TO RECEIVE ADDITIONAL SUCCESS-BASED REGULATORY AND SALES MILESTONE PAYMENTS OF UP TO $168 MILLION
- BRICKELL BIOTECH INC - BOTANIX WILL BE RESPONSIBLE FOR ALL FURTHER RESEARCH, DEVELOPMENT, AND COMMERCIALIZATION OF SOFPIRONIUM BROMIDE GLOBALLY
News: BOT Brickell Biotech Announces Sale Of Sofpironium Bromide To Botanix Pharmaceuticals
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.055(16.9%) |
Mkt cap ! $660.6M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 38.0¢ | 33.0¢ | $6.611M | 18.33M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 368546 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.59pm 12/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |